emopamil has been researched along with Brain Vascular Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunter, AJ | 1 |
| Hofmann, HP; Raschack, M; Unger, L | 1 |
1 review(s) available for emopamil and Brain Vascular Disorders
| Article | Year |
|---|---|
Calcium antagonists: their role in neuroprotection.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels; Cerebrovascular Disorders; Dihydropyridines; Flunarizine; Humans; Neuroprotective Agents; Verapamil | 1997 |
1 other study(ies) available for emopamil and Brain Vascular Disorders
| Article | Year |
|---|---|
(S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Cerebrovascular Disorders; Female; Guinea Pigs; In Vitro Techniques; Ischemic Attack, Transient; Ketanserin; Male; Membranes; Mice; Muscle, Smooth, Vascular; Muscles; Myocardial Contraction; Rats; Rats, Inbred Strains; Serotonin Antagonists; Verapamil | 1989 |